Martin R. Farlow, MD, Indiana University 1979
Affiliations: | Neurology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=87Website:
http://iadc.iupui.edu/iadc-faculty/martin-r-farlow-md/Google:
"Martin Farlow"Bio:
http://www.iupui.edu/~medneuro/FacultyPages/farlow.htm
http://www.labome.org/expert/usa/indiana/farlow/martin-r-farlow-288175.html
http://newsinfo.iu.edu/sb/page/normal/81.html
Mean distance: 106866
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Llibre-Guerra JJ, Iaccarino L, Coble D, et al. (2023) Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280 |
| Johnson ECB, Bian S, Haque RU, et al. (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine |
| Swinford CG, Risacher SL, Vosmeier A, et al. (2023) Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease. Neurobiology of Aging. 130: 103-113 |
| Schultz SA, Shirzadi Z, Schultz AP, et al. (2023) Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. e13871 |
| Merrihew GE, Park J, Plubell D, et al. (2023) A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer's disease. Scientific Data. 10: 206 |
| Chatterjee P, Vermunt L, Gordon BA, et al. (2022) Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Ali M, Sung YJ, Wang F, et al. (2022) Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk. Plos One. 17: e0267298 |
| Morris JC, Weiner M, Xiong C, et al. (2022) Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology |
| Shahid SS, Wen Q, Risacher SL, et al. (2022) Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease. Brain : a Journal of Neurology |
| Salloway S, Farlow M, McDade E, et al. (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine |